Detalles de la búsqueda
1.
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study.
Am J Hematol
; 97(3): E83-E86, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882831
2.
Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone.
Am J Hematol
; 96(10): E383-E386, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161627
Resultados
1 -
2
de 2
1
Próxima >
>>